Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
IndegeneNSE:INDGN +0.77%49 PE Ratio (TTM) is 33.40 as of Aug. 07, 2026, which is 4% above its 10-year median of 32.05. GuruFocus rates NSE:INDGN with a GF Score™ of 49/100. The stock has 6 warning signs investors should review. Among 431 Healthcare Providers & Services companies, Indegene ranks worse than 68.21% on this metric.
The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2026-08-07), Indegene's share price is
₹554.45.
Indegene's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 was ₹16.60. Therefore, Indegene's PE Ratio (TTM) for today is 33.40.
Warning Sign:
Indegene Ltd stock PE Ratio (=32.55) is close to 1-year high of 32.55.
The historical rank and industry rank for Indegene's PE Ratio (TTM) or its related term are showing as below:
NSE:INDGN'
s PE Ratio (TTM) Range Over the Past 10 Years
Min: 23.6 Med: 32.05 Max: 45.25
Current: 33.41
During the past 6 years, the highest PE Ratio (TTM) of Indegene was 45.25. The lowest was 23.60. And the median was 32.05.
NSE:INDGN's PE Ratio (TTM) is ranked worse than 68.21% of 431
companies
in the Healthcare Providers & Services industry
Industry Median: 21.79
vs NSE:INDGN: 33.41
As of today (2026-08-07), Indegene's share price is ₹554.45.
Indegene's EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2026 was ₹17.24. Therefore, Indegene's PE Ratio without NRI for today is 32.17.
During the past 6 years, Indegene's highestPE Ratio without NRI was 64.97. The lowest was 23.60. And the median was 32.50.
Indegene's EPS without NRI for the
three
months ended in Jun. 2026 was ₹4.81.
Its EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2026 was ₹17.24.
During the past 12 months, Indegene's average EPS without NRIGrowth Rate was -4.50% per year.
During the past 3 years, the average EPS without NRIGrowth Rate was 13.60% per year.
During the past 5 years, the average EPS without NRIGrowth Rate was 20.70% per year.
During the past 6 years, Indegene's highest 3-Year average EPS without NRI Growth Rate was 24.00% per year. The lowest was 13.60% per year. And the median was 15.00% per year.
Indegene's EPS (Basic) for the
three
months ended in Jun. 2026 was ₹4.84.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2026 was ₹16.71.
The PE Ratio (TTM) can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio (TTM) is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.
In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio (TTM) is positive. Also for stocks with the same PE Ratio (TTM), the one with faster growth business is more attractive.
If a company loses money, the PE Ratio (TTM) becomes meaningless.
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio (TTM) divided by the growth ratio. He thinks a company with a PE Ratio (TTM) equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio (TTM) of 20, instead of a company growing 10% a year with a PE Ratio (TTM) of 10.
Because the PE Ratio (TTM) measures how long it takes to earn back the price you pay, the PE Ratio (TTM) can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.
Investors need to be aware that the PE Ratio (TTM) can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio (TTM)s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio (TTM) is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio .
PE Ratio (TTM) can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio (TTM).
Indegene PE Ratio (TTM) Related Terms
Indegene PE Ratio (TTM) Historical Data
* Premium members only.
The historical data trend for Indegene's PE Ratio (TTM) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:INDGN vs VEEV, BTSG, HQY: PE Ratio (TTM) Comparison
For the Health Information Services subindustry, Indegene's PE Ratio (TTM), along with its competitors' market caps and PE Ratio (TTM) data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Indegene PE Ratio (TTM) vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Indegene's PE Ratio (TTM) distribution charts can be found below:
* The bar in red indicates where Indegene's PE Ratio (TTM) falls into.
The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.
Indegene's PE Ratio (TTM) for today is calculated as
Indegene's Share Price of today is ₹554.45.
Indegene's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹16.60.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
There are at least three kinds of PE Ratio (TTM)s used by different investors. They are Trailing Twelve Month PE Ratio (TTM) or PE Ratio (TTM) (TTM), Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio (TTM) based on inflation-adjusted normalized PE Ratio (TTM) is called Shiller PE Ratio, after Yale professor Robert Shiller.
In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.
For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.
Indegene (NSE:INDGN) has a PE Ratio (TTM) of 33.40 as of Aug. 07, 2026. Trailing 12-month P/E ratio is the ratio of share price to a company's trailing 12-month earnings per share. View historical data on Indegene and its competitors. This is near median its historical median of 32.05. Over the past decade, Indegene's PE Ratio (TTM) has ranged from 23.60 to 45.25. According to the industry distribution chart, Indegene ranks #294 out of 431 companies in the Healthcare Providers & Services industry, placing it in the top 68.2%.
Is Indegene's PE Ratio (TTM) too high?
Indegene's current PE Ratio (TTM) of 33.40 is near median its 10-year median of 32.05. Over the past 10 years, this metric has ranged from a low of 23.60 to a high of 45.25. The Healthcare Providers & Services industry median PE Ratio (TTM) is 21.79. Indegene's value of 33.40 is 53.3% above this industry median. Based on the distribution chart, Indegene ranks #294 out of 431 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Indegene has a GF Score™ of 49/100, reflecting its overall financial health beyond just this single metric.
How does Indegene's PE Ratio (TTM) compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Indegene ranks #294 out of 431 companies for PE Ratio (TTM). This places Indegene in the lower half of its industry. The industry median PE Ratio (TTM) is 21.79. Indegene's value of 33.40 is 53.3% above this benchmark. Historically, Indegene's own PE Ratio (TTM) has ranged from 23.60 to 45.25 over the past decade. While the company's 10-year median is 32.05 vs. the industry median of 21.79, Indegene has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio (TTM) for a Healthcare Providers & Services company?
The median PE Ratio (TTM) among Healthcare Providers & Services companies is 21.79, based on 431 companies in the industry. Companies in the top quartile (top 25%) have a PE Ratio (TTM) significantly above this median, while those in the bottom quartile fall well below. However, PE Ratio (TTM) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Indegene's current PE Ratio (TTM) of 33.40 is 53.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio (TTM) mean?
A high PE Ratio (TTM) can signal that a stock is expensive relative to its fundamentals. Trailing 12-month P/E ratio is the ratio of share price to a company's trailing 12-month earnings per share. View historical data on Indegene and its competitors. For the Healthcare Providers & Services industry, the median PE Ratio (TTM) is 21.79 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Indegene's current PE Ratio (TTM) is 33.40, which is near median its own 10-year median of 32.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indegene stock overvalued right now?
Indegene (NSE:INDGN) has a current PE Ratio (TTM) of 33.40. The current PE Ratio (TTM) is 33.40, which is near median its 10-year median of 32.05 and 53.3% above the Healthcare Providers & Services industry median of 21.79. Indegene's overall GF Score™ is 49/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio (TTM) calculated?
PE Ratio (TTM) is calculated from a company's financial statements. For Indegene (NSE:INDGN), the current PE Ratio (TTM) is 33.40 as of Aug. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Indegene Ltd provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech, and medical device companies. It assists them with drug development and clinical trials, regulatory submissions, pharmacovigilance and complaints management, and the sales and marketing of their products. Its portfolio of solutions covers all aspects of commercial, medical, regulatory, and R&D operations for life sciences companies. The company's segments include Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation, and Others. Key revenue is generated from the Omnichannel Activation segment. The company has a presence in India, Europe, and North America, with the majority of revenue coming from North America.
49GF Score
Get the complete analysis for NSE:INDGN
PE Ratio (TTM) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:INDGN has been successfully added to your 
